Markus Rohrwild Email & Phone Number
Chief Executive Officer @ Gubra
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Markus Rohrwild Location
- Denmark
Markus Rohrwild Work
- Chief Executive Officer @ (September 2025 - Present)
- Chairman of the Board @ (February 2021 - Present)
- Vice President Governance @ (May 2024 - April 2025)
- Vice President Governance @ (January 2020 - July 2022)
- Chairman of the Board @ (January 2021 - Present)
- Chief Executive Officer and Managing Director @ (January 2021 - April 2024)
- Chief Executive Officer and Managing Director @ Emavant Solutions (January 2018 - December 2019)
- Global Business Franchise Head Cardio-Metabolic Medicines @ (October 2014 - December 2017)
- Global Business Franchise Head Ophthalmics @ (April 2013 - September 2014)
- Head Pharma and President Novartis Taiwan @ (April 2011 - March 2013)
- Head Marketing and Sales Region AMAC (Asia-Pacific, Middle East and African Countries) @ (March 2009 - March 2011)
- Global Brand Head Rasilez and Tekturna @ (July 2007 - February 2009)
- Business Franchise Head Cardiovascular and Metabolism in Germany @ (October 2006 - June 2007)
- Leadership Development Program (Sales Rotation in Germany) @ (November 2005 - September 2006)
- Global Head New Products and Portfolio Strategy @ (April 2005 - October 2005)
- Global Disease Area Strategy Director @ (June 2003 - March 2005)
- Engagement Manager in Frankfurt Office, Germany @ (September 1999 - May 2003)
- Head of Biochemistry @ Hoechst Roussel Vet GmbH (now part of MSD Animal Health) (March 1998 - August 1999)
Markus Rohrwild Education
- Harvard Medical School
PhD
1994-1998 - University of Applied Sciences Weihenstephan-Triesdorf
Dipl. Ing. FH
1989-1994
Markus Rohrwild Skills
- Acquisition Integration
- Biopharmaceuticals
- Biotechnology
- Board of Directors
- Business Analysis
- Business Development
- Business Strategy
- Cardiology
- Clinical Trials
- Cross-functional Team Leadership
- Diabetes
- Digital Innovation
- Drug Discovery
- Emerging Markets
- Global Marketing
- Global Strategy
- Health Economics
- Hospital Sales
- Infectious Diseases
- Lead Change
- Life Sciences
- Management
- Management Consulting
- Market Access
- Market Analysis
- Marketing Strategy
- Mergers & Acquisitions
- Oncology
- Operational Excellence
- Pharmaceutical Industry
- Pharmaceutical Sales
- Pharmaceutics
- Pipeline Development
- Product Launch
- R&D
- Sales Effectiveness
- Start-up Ventures
- Strategic Leadership
- Strategic Planning
- Strategy
- Talent Developer
- Team Leadership
- Vaccines
Markus Rohrwild Summary
- Markus Rohrwild, based in Denmark, is currently a Chief Executive Officer at Gubra. Markus Rohrwild brings experience from previous roles at Roivant and Genevant Sciences. Markus Rohrwild holds a 1994 - 1998 PhD @ Harvard Medical School. With a robust skill set that includes Acquisition Integration, Biopharmaceuticals, Biotechnology, Board of Directors, Business Analysis and more. Markus Rohrwild has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Markus Rohrwild?
Find contact details for 700 million professionals.
Top Gubra Employees
Jacob Voltelen
Vice President, Head of People and Culture
Copenhagen, DK
Louise Dalbøge
Chief Science Officer
Hørsholm, DK
Trine Hamann
Head of Gubra CRO
Copenhagen, DK
Adam Lange
Head of Investor Relations
Copenhagen, DK
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co